HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the
latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored:
- HBV Liver Cancer Requires Aggressive Treatment from the Start
- Experts: Treat Cirrhotic Patients, Even if Viral Load Is Low
- Some Patients Can Safely Stop Antiviral After Four Years
- Tenofovir Safe and Effective in Pregnant Women with Drug Resistance
- Researchers Discover Why Children Become Chronically Infected
- Expert Recommends Treatment for Mental Confusion from Cirrhosis
- Antivirals Increase Survival After Liver Cancer Treatment
- HBV Patients with Diabetes Have a Higher Risk of Liver Cancer
- Long-term Antiviral Use Increases Hip Fracture Rates Slightly
- Second Vaccine Series May Be Needed for Children with Celiac Disease
- Researchers Find HBV B Strain in Cuba Did Not Come from Africa
Continue reading "HBV Journal Review – June 2015"